The biotechnology business is unusual compared to many sectors in that many companies are acquired or IPO without any revenue or product. It is common for biotech start-ups as they are science-based often with technologies that have originated from universities or technical institutes. Therefore a dominating feature of these companies is that licensing is a major component of these businesses. Biotech start-ups almost never produce and sell biopharmaceuticals. They instead license their intellectual property (IP) to large pharmaceutical companies. However, they themselves have generally licensed IP from universities where the discoveries have been made and protected through patent applications.
The terms of the licenses from the university to the biotech-startup is critical. The questions that commonly arise are:
Therefore it is absolutely vital to have the right experience with both the technical and commercial aspects of a project to get this right from the outset. Failing to do so could have catastrophic consequences years later. GRA has experience of helping construct licensing agreements as well as general agreements, whether with academia, other technology companies or large multinational pharmaceutical companies. Please contact us if you wish to discuss.
Complete your details and we’ll send you regular updates via our newsletter.
Need to understand some element of the biopharma industry or looking for a particular template?
© 2023 GreyRigge Associates Limited. All rights reserved.
Site design & build by Hinge Ltd.